Bioventix (BVXP) Competitors

Bioventix (LON:BVXP) and Ergomed (LON:ERGO) are both small-cap medical companies, but which is the better investment? We will compare the two businesses based on the strength of their dividends, risk, earnings, profitability, institutional ownership, valuation, media sentiment, analyst recommendations and community ranking.

Is BVXP or ERGO more profitable?

Bioventix has a net margin of 63.73% compared to Ergomed's net margin of 9.87%. Bioventix's return on equity of 79.14% beat Ergomed's return on equity.

Company	Net Margins	Return on Equity	Return on Assets
Bioventix	63.73%	79.14%	54.07%
Ergomed	9.87%	18.08%	10.16%

Does the MarketBeat Community favor BVXP or ERGO?

Ergomed received 150 more outperform votes than Bioventix when rated by MarketBeat users. Likewise, 75.63% of users gave Ergomed an outperform vote while only 52.87% of users gave Bioventix an outperform vote.

Company	Underperform	Outperform
Bioventix	Outperform Votes 92 52.87%	Underperform Votes 82 47.13%
Ergomed	Outperform Votes 242 75.63%	Underperform Votes 78 24.38%

Does the media refer more to BVXP or ERGO?

In the previous week, Bioventix had 1 more articles in the media than Ergomed. MarketBeat recorded 1 mentions for Bioventix and 0 mentions for Ergomed. Bioventix's average media sentiment score of 0.75 beat Ergomed's score of 0.00 indicating that Bioventix is being referred to more favorably in the media.

Company	Overall Sentiment
Bioventix	Positive
Ergomed	Neutral

Which has higher valuation and earnings, BVXP or ERGO?

Ergomed has higher revenue and earnings than Bioventix. Bioventix is trading at a lower price-to-earnings ratio than Ergomed, indicating that it is currently the more affordable of the two stocks.

Company	Gross Revenue	Price/Sales Ratio	Net Income	Earnings Per Share	Price/Earnings Ratio
Bioventix	£13.60M	14.68	£8.67M	£1.63	2,346.63
Ergomed	£152.09M	4.61	£15M	£0.29	4,641.38

Do insiders and institutionals have more ownership in BVXP or ERGO?

62.3% of Bioventix shares are held by institutional investors. Comparatively, 71.1% of Ergomed shares are held by institutional investors. 8.0% of Bioventix shares are held by insiders. Comparatively, 18.2% of Ergomed shares are held by insiders. Strong institutional ownership is an indication that large money managers, endowments and hedge funds believe a company will outperform the market over the long term.

Which has more volatility and risk, BVXP or ERGO?

Bioventix has a beta of 0.35, indicating that its stock price is 65% less volatile than the S&P 500. Comparatively, Ergomed has a beta of 0.79, indicating that its stock price is 21% less volatile than the S&P 500.

Summary

Ergomed beats Bioventix on 8 of the 15 factors compared between the two stocks.